Stockreport

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Reported Earnings, And Analysts Cut Their Target Price [Yahoo! Finance]

Maravai LifeSciences Holdings, Inc. - Class A common stock  (MRVI) 
PDF It was a pretty negative result overall, with revenues of US$65m missing analyst predictions by 3.7%. Worse, the business reported a statutory loss of US$0.70 per share, [Read more]